rs156429

Variant names:

• chr7-23266401-T-A
• rs156429
• NM_002510.3:c.1019-116T>A

Your query was ambiguous. Multiple possible variants found:

• chr7-23266401-T-A
• chr7-23266401-T-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2 BP4_Strong

The NM_002510.3(GPNMB):​c.1019-116T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000521 in 767,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency:
  • Genomes: not found (cov: 32)
  • Exomes 𝑓: 0.0000052 (0 hom.)
• Consequence: GPNMB NM_002510.3 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.0540
• Publications: 0 publications found

Genes affected

GPNMB (HGNC:4462): (glycoprotein nmb) The protein encoded by this gene is a type I transmembrane glycoprotein which shows homology to the pMEL17 precursor, a melanocyte-specific protein. GPNMB shows expression in the lowly metastatic human melanoma cell lines and xenografts but does not show expression in the highly metastatic cell lines. GPNMB may be involved in growth delay and reduction of metastatic potential. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

GPNMB Gene-Disease associations (from GenCC):

• amyloidosis, primary localized cutaneous, 3

  Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

ACMG classification

Our verdict: Likely_benign. The variant received -2 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.89).

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
GPNMB	NM_002510.3	c.1019-116T>A		intron_variant	Intron 6 of 10	ENST00000258733.9	NP_002501.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
GPNMB	ENST00000258733.9	c.1019-116T>A		intron_variant	Intron 6 of 10	1	NM_002510.3	ENSP00000258733.5
GPNMB	ENST00000381990.6	c.1019-80T>A		intron_variant	Intron 6 of 10	1		ENSP00000371420.2
GPNMB	ENST00000479625.1	n.262T>A		non_coding_transcript_exon_variant	Exon 1 of 3	2
GPNMB	ENST00000647578.1	c.1103-116T>A		intron_variant	Intron 7 of 11			ENSP00000497362.1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome AF: 0.00000521 AC: 4 AN: 767092 Hom.: 0 Cov.: 10 AF XY: 0.00000753 AC XY: 3 AN XY: 398582

⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.

African (AFR) AF: 0.00 AC: 0 AN: 19256

American (AMR) AF: 0.00 AC: 0 AN: 29068

Ashkenazi Jewish (ASJ) AF: 0.0000582 AC: 1 AN: 17184

East Asian (EAS) AF: 0.00 AC: 0 AN: 35816

South Asian (SAS) AF: 0.0000171 AC: 1 AN: 58388

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 46840

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 3794

European-Non Finnish (NFE) AF: 0.00000384 AC: 2 AN: 520170

Other (OTH) AF: 0.00 AC: 0 AN: 36576

⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.00667379), which strongly suggests a high chance of mosaicism in these individuals.

GnomAD4 genome Cov.: 32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.89
CADD	Benign	0.64
DANN	Benign	0.33
PhyloP100		-0.054

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs156429; hg19: chr7-23306020;